SCHEMBL19998730

SCHEMBL19998730

Cc1cc(C)cc(-c2ccc(N(c3ccccc3)c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
HDAC4 P56524 1/20 0.39
APP P05067 1/20 0.38
ALDH1A1 P00352 4/20 0.35
MAPT P10636 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
MAPK8 P45983 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19998732 1.00 KDM4E (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998757 1.00 KDM4E (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998733 0.97 L3MBTL1 (0.44) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998889 0.97 L3MBTL1 (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998891 0.97 L3MBTL1 (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998736 0.97 L3MBTL1 (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998737 0.96 L3MBTL1 (0.45) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998754 0.95 KDM4E (0.41) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998883 0.94 KDM4E (0.46) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL19998886 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 KDM4E 1587/4885L3MBTL1 1552/4885ATM 3732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.